ProQR Announces Financial Results for the Second Quarter of 2019 Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Aug. August 07, 2019
ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update Press release Key updates February 28, 2017
ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update Press release Key updates February 28, 2018
ProQR’s Drug Candidate QRX-421 for Usher Syndrome Receives Orphan Drug Designation from FDA and EMA Press release Key Updates September 05, 2017
ProQR’s Drug Candidate QRX-411 for Usher Syndrome Receives Orphan Drug Designation from FDA and EMA Press release Key Updates July 05, 2017
ProQR lizenziert weltweite Rechte für Arzneimittelkandidaten für die Augenheilkunde von Ionis Pharmaceuticals Press release … der Association for Research in Vision and Ophthalmology (ARVO) vorgestellt und in einem Peer-Review-Artikel, Murray et … October 30, 2018
ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticals Press release ProQR receives exclusive worldwide license for IONIS-RHO-2.5Rx, now QR-1123, for autosomal dominant retinitis pigmentosa (adRP), a rare inherited form of blindness with no approved therapy October 29, 2018
ProQR Doses First LCA 10 Patient in Clinical Trial of QR-110, ProQR’s Lead Program for Genetic Blindness Press release Key Updates November 13, 2017
ProQR Announces Results for the First Quarter of 2016 Press release LEIDEN, the Netherlands, May 18, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. May 18, 2016